ELEVANCE HEALTH INC (A58.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:A58 - US0367521038 - Common Stock
319 EUR
-1.9 (-0.59%)
A58 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 32 industry peers in the Health Care Providers & Services industry. A58 has a medium profitability rating, but doesn't score so well on its financial health evaluation. A58 is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- A58 had positive earnings in the past year.
- A58 had a positive operating cash flow in the past year.
- Each year in the past 5 years A58 has been profitable.
- Each year in the past 5 years A58 had a positive operating cash flow.
1.2 Ratios
- A58's Return On Assets of 4.51% is amongst the best of the industry. A58 outperforms 81.25% of its industry peers.
- Looking at the Return On Equity, with a value of 12.59%, A58 is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 5.60%, A58 is in line with its industry, outperforming 50.00% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for A58 is in line with the industry average of 7.02%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROIC | 5.6% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
- A58 has a better Profit Margin (2.84%) than 65.63% of its industry peers.
- A58's Profit Margin has declined in the last couple of years.
- A58's Operating Margin of 4.35% is in line compared to the rest of the industry. A58 outperforms 53.13% of its industry peers.
- In the last couple of years the Operating Margin of A58 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- A58 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- A58 has less shares outstanding than it did 1 year ago.
- A58 has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, A58 has a worse debt to assets ratio.
2.2 Solvency
- The Debt to FCF ratio of A58 is 8.63, which is on the high side as it means it would take A58, 8.63 years of fcf income to pay off all of its debts.
- A58 has a Debt to FCF ratio of 8.63. This is comparable to the rest of the industry: A58 outperforms 56.25% of its industry peers.
- A Debt/Equity ratio of 0.71 indicates that A58 is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.71, A58 is in the better half of the industry, outperforming 78.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Altman-Z | N/A |
ROIC/WACC0.67
WACC8.41%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
- The earnings per share for A58 have decreased strongly by -11.71% in the last year.
- Measured over the past years, A58 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.17% on average per year.
- A58 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.96%.
- Measured over the past years, A58 shows a quite strong growth in Revenue. The Revenue has been growing by 11.14% on average per year.
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%10.95%
3.2 Future
- The Earnings Per Share is expected to grow by 7.64% on average over the next years.
- A58 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.62% yearly.
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.64%
Revenue Next Year13.06%
Revenue Next 2Y8.17%
Revenue Next 3Y6.96%
Revenue Next 5Y4.62%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 12.12, A58 is valued correctly.
- A58's Price/Earnings ratio is a bit cheaper when compared to the industry. A58 is cheaper than 71.88% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.30, A58 is valued rather cheaply.
- A58 is valuated correctly with a Price/Forward Earnings ratio of 13.61.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of A58 indicates a somewhat cheap valuation: A58 is cheaper than 62.50% of the companies listed in the same industry.
- A58's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.12 | ||
| Fwd PE | 13.61 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of A58 is on the same level as its industry peers.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of A58 indicates a slightly more expensive valuation: A58 is more expensive than 68.75% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.2 | ||
| EV/EBITDA | 10.57 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)1.08
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
5. Dividend
5.1 Amount
- A58 has a Yearly Dividend Yield of 1.83%.
- Compared to an average industry Dividend Yield of 1.57, A58 has a dividend in line with its industry peers.
- A58's Dividend Yield is comparable with the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.83% |
5.2 History
- The dividend of A58 is nicely growing with an annual growth rate of 15.34%!
Dividend Growth(5Y)15.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- A58 pays out 27.56% of its income as dividend. This is a sustainable payout ratio.
- The dividend of A58 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27.56%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
FRA:A58 (1/13/2026, 7:00:00 PM)
319
-1.9 (-0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-21 2025-10-21/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners91.68%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap70.89B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Analysts73.57
Price Target339.49 (6.42%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.83% |
Yearly Dividend5.63
Dividend Growth(5Y)15.34%
DP27.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.38%
Min EPS beat(2)-2.26%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)5
Avg EPS beat(8)0.95%
EPS beat(12)8
Avg EPS beat(12)1.31%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)2
Avg Revenue beat(2)0.95%
Min Revenue beat(2)0.45%
Max Revenue beat(2)1.45%
Revenue beat(4)4
Avg Revenue beat(4)1.62%
Min Revenue beat(4)0.29%
Max Revenue beat(4)4.3%
Revenue beat(8)7
Avg Revenue beat(8)1.16%
Revenue beat(12)9
Avg Revenue beat(12)1.25%
Revenue beat(16)12
Avg Revenue beat(16)1.04%
PT rev (1m)1.09%
PT rev (3m)6.57%
EPS NQ rev (1m)-1.44%
EPS NQ rev (3m)-23.7%
EPS NY rev (1m)0%
EPS NY rev (3m)0.31%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.12 | ||
| Fwd PE | 13.61 | ||
| P/S | 0.42 | ||
| P/FCF | 22.2 | ||
| P/OCF | 16.98 | ||
| P/B | 1.88 | ||
| P/tB | 19.79 | ||
| EV/EBITDA | 10.57 |
EPS(TTM)26.33
EY8.25%
EPS(NY)23.43
Fwd EY7.35%
FCF(TTM)14.37
FCFY4.5%
OCF(TTM)18.79
OCFY5.89%
SpS752.21
BVpS169.7
TBVpS16.12
PEG (NY)N/A
PEG (5Y)1.08
Graham Number317.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROCE | 7.32% | ||
| ROIC | 5.6% | ||
| ROICexc | 6.06% | ||
| ROICexgc | 10.93% | ||
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A | ||
| FCFM | 1.91% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Debt/EBITDA | 3.13 | ||
| Cap/Depr | 74.45% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.59% | ||
| Profit Quality | 67.25% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score4
WACC8.41%
ROIC/WACC0.67
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.64%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%10.95%
Revenue Next Year13.06%
Revenue Next 2Y8.17%
Revenue Next 3Y6.96%
Revenue Next 5Y4.62%
EBIT growth 1Y-10.69%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-2.04%
EBIT Next 3Y0.56%
EBIT Next 5Y8.31%
FCF growth 1Y-54.88%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-48.85%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%
ELEVANCE HEALTH INC / A58.DE FAQ
Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?
ChartMill assigns a fundamental rating of 4 / 10 to A58.DE.
What is the valuation status of ELEVANCE HEALTH INC (A58.DE) stock?
ChartMill assigns a valuation rating of 3 / 10 to ELEVANCE HEALTH INC (A58.DE). This can be considered as Overvalued.
What is the profitability of A58 stock?
ELEVANCE HEALTH INC (A58.DE) has a profitability rating of 5 / 10.
Can you provide the expected EPS growth for A58 stock?
The Earnings per Share (EPS) of ELEVANCE HEALTH INC (A58.DE) is expected to decline by -8.14% in the next year.
Is the dividend of ELEVANCE HEALTH INC sustainable?
The dividend rating of ELEVANCE HEALTH INC (A58.DE) is 4 / 10 and the dividend payout ratio is 27.56%.